Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis

BACKGROUND: Beta-interferon (IFN-β) and glatiramer acetate (GA) have been evaluated in people with clinically isolated syndrome (CIS) with the aim to delay a second clinical attack and a diagnosis of clinically definite multiple sclerosis (CDMS). We systematically reviewed trials evaluating the shor...

Descripción completa

Detalles Bibliográficos
Autores principales: Armoiry, X., Kan, A., Melendez-Torres, G. J., Court, R., Sutcliffe, P., Auguste, P., Madan, J., Counsell, C., Clarke, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937891/
https://www.ncbi.nlm.nih.gov/pubmed/29356977
http://dx.doi.org/10.1007/s00415-018-8752-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937891/
https://www.ncbi.nlm.nih.gov/pubmed/29356977
http://dx.doi.org/10.1007/s00415-018-8752-8

Ejemplares similares